Oura’s $2.2 billion market debut lets early backers cash out
The Finnish health‑tracker’s IPO is set to raise $2.2 billion, with Forerunner Ventures looking to sell its whole stake for up to $1.26 billion.

Finnish wearable maker Oura announced plans for a $2.2 billion initial public offering that would list the company on a U.S. exchange, according to filing details reported by TechCrunch. The prospectus shows that venture capital firm Forerunner Ventures intends to divest its entire holding, potentially pocketing as much as $1.26 billion from the transaction.
The filing indicates Oura will offer roughly 30 million shares at a price range of $70 to $75 per share. If the shares price at the top of the range, the company would secure about $2.2 billion in gross proceeds, a figure that places the debut among the larger tech listings of the year.
Forerunner’s exit is notable because the firm entered Oura’s early financing rounds and has watched the health‑monitoring startup grow from a niche sleep‑tracker to a broader wellness platform. By selling its full position, Forerunner stands to realize a substantial return on its original investment, effectively turning the IPO into a payday for its limited partners.
Why the IPO matters
Oura’s move comes at a time when consumer‑focused health wearables are seeking fresh capital to expand beyond core sleep‑tracking features. The market, dominated by Apple, Fitbit (now Google), and Garmin, has seen a surge in demand for devices that integrate biometric data with lifestyle coaching. Analysts note that Oura’s subscription‑based model, which pairs hardware with a monthly analytics service, aligns with the broader industry shift toward recurring revenue streams. The proceeds from the offering are expected to fund research into new sensor technologies, broaden the company’s retail footprint, and accelerate entry into the corporate wellness space.
The IPO also reflects a broader trend of venture‑backed hardware firms turning to public markets after years of private funding. Similar routes have been taken by companies such as Whoop and Oura’s own competitor, Whoop, which listed earlier this year. Investors are watching whether Oura can sustain growth once the novelty of its sleep‑focused branding gives way to more competitive pressures.
If the offering proceeds as outlined, existing shareholders like Forerunner will walk away with a sizable windfall, while new investors will gain exposure to a company positioned at the intersection of health data, consumer electronics, and subscription services. The market’s reaction in the coming weeks will likely set the tone for other wearable startups considering a public listing.
This report is based on original reporting by TechCrunch. Read the original source →